All In MedTech

Device Trial Radar · NCT01788085

Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore)

RD-41 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance

Last checked: Nov 19, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Aug 2013

Primary completion

Mar 2014

Study completion Mar 2014

Sponsor

Lead sponsor
Medtronic - MITGPublic (MDT)
Sponsor type
Industry
First posted
Feb 11, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study Hypothesis: This study is designed as an integral part of the development of new or improved features or components of the Bravo® pH Monitoring System and may serve verification and validation purposes. The study population will include symptomatic patients with known or suspected gastroesophageal reflux disease Symptomatic patients will undergo invasive procedure, including Bravo capsule delivery, positioning and attachment. Confirmation of capsule attachment may be done endoscopically. These procedures will serve to evaluate overall system performance in actual clinical setup, for instance: ergonomics and performance of delivery device, capsule transmission etc. Physician may be asked to provide feedback on the procedure and/or document their activities during the procedure.

Conditions

  • Gastro Esophageal Reflux Disease

Interventions

  • Bravo pH monitoring procedureDevice

    Bravo pH monitoring procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate physician subjective assessment questionnaireTime frame: post Bravo pH monitoring pinning procedure, same day of procedure
  2. Percentage of successful capsule attachmentsTime frame: post Bravo pH monitoring pinning procedure, same day of procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bnei-Zion MC

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.